FBH1
Basic information
Region (hg38): 10:5890203-5937594
Previous symbols: [ "FBXO18" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (133 variants)
- Prostate_cancer (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBH1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000178150.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 116 | 124 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 116 | 8 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBH1 | protein_coding | protein_coding | ENST00000379999 | 22 | 48022 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000822 | 1.00 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.82 | 453 | 656 | 0.690 | 0.0000388 | 7211 |
Missense in Polyphen | 92 | 216.22 | 0.4255 | 2474 | ||
Synonymous | 0.493 | 250 | 260 | 0.961 | 0.0000170 | 2085 |
Loss of Function | 4.69 | 18 | 55.8 | 0.323 | 0.00000289 | 636 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000182 | 0.000181 |
Ashkenazi Jewish | 0.00160 | 0.00159 |
East Asian | 0.000817 | 0.000816 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.000817 | 0.000816 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: 3'-5' DNA helicase and substrate-recognition component of the SCF(FBH1) E3 ubiquitin ligase complex that plays a key role in response to stalled/damaged replication forks (PubMed:11956208, PubMed:23393192). Involved in genome maintenance by acting as an anti-recombinogenic helicase and preventing extensive strand exchange during homologous recombination: promotes RAD51 filament dissolution from stalled forks, thereby inhibiting homologous recombination and preventing excessive recombination (PubMed:17724085, PubMed:19736316). Also promotes cell death and DNA double-strand breakage in response to replication stress: together with MUS81, promotes the endonucleolytic DNA cleavage following prolonged replication stress via its helicase activity, possibly to eliminate cells with excessive replication stress (PubMed:23319600, PubMed:23361013). Plays a major role in remodeling of stalled DNA forks by catalyzing fork regression, in which the fork reverses and the two nascent DNA strands anneal (PubMed:25772361). In addition to the helicase activity, also acts as the substrate-recognition component of the SCF(FBH1) E3 ubiquitin ligase complex, a complex that mediates ubiquitination of RAD51, leading to regulate RAD51 subcellular location (PubMed:25585578). {ECO:0000269|PubMed:11956208, ECO:0000269|PubMed:17724085, ECO:0000269|PubMed:19736316, ECO:0000269|PubMed:23319600, ECO:0000269|PubMed:23361013, ECO:0000269|PubMed:25585578, ECO:0000269|PubMed:25772361}.;
- Disease
- DISEASE: Note=Defects in FBH1 are frequently observed in melanomas, resulting in increased survival in response to replicative stress. Its inactivation may play a role in oncogenic transformation. {ECO:0000269|PubMed:23466708}.;
Recessive Scores
- pRec
- 0.0981
Intolerance Scores
- loftool
- rvis_EVS
- -2.03
- rvis_percentile_EVS
- 1.68
Haploinsufficiency Scores
- pHI
- 0.151
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.605
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Fbh1
- Phenotype
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;recombinational repair;DNA catabolic process, endonucleolytic;positive regulation of protein phosphorylation;DNA repair;cellular response to DNA damage stimulus;cell death;protein ubiquitination;replication fork processing;DNA duplex unwinding;negative regulation of chromatin binding;replication fork protection;response to intra-S DNA damage checkpoint signaling;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage;negative regulation of double-strand break repair via homologous recombination
- Cellular component
- chromatin;nucleus;SCF ubiquitin ligase complex
- Molecular function
- DNA helicase activity;double-stranded DNA binding;single-stranded DNA binding;protein binding;DNA translocase activity;3'-5' DNA helicase activity;ATP-dependent 3'-5' DNA helicase activity